person · Reporting owner

Rittenmeyer Ronald A

Disclosed activity across 5 companies

Tapewire entity: 123368
SEC CIK: 0001210018

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083	Director	April 01, 2019	April 02, 2019
Avaya Holdings Corp.AVYA · Entity 117306	Director	March 15, 2018	March 15, 2018
IQVIA HOLDINGS INC.IQV · Entity 3058	Director	May 11, 2022	May 13, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AMERICAN INTERNATIONAL GROUP, INC.

Report date April 01, 2019 · Filed April 02, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Deferred Stock UnitSEC Table II · derivative / convertible security	Direct	19,537	Reported balance After 2019-04-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2019-04-01 · Grant · Acquired 140 · Balance 19,537 F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. F2: Reflects deferred stock units previously granted pursuant to the 2010 Plan and the 2013 Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG.

F2: Reflects deferred stock units previously granted pursuant to the 2010 Plan and the 2013 Plan.

Avaya Holdings Corp.

Report date March 15, 2018 · Filed March 15, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	Direct	3,211	Reported balance After 2018-03-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2018-03-15 · Exercise / conversion · Acquired 3,211 · Balance 3,211 F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	9,636	Reported balance After 2018-03-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-03-15 · Exercise / conversion · Disposed 3,211 · Balance 9,636 F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP. F2: Represents Restricted Stock Units that have vested as the Common Stock set forth in Table I.

Filing footnotes · ownership attribution and instrument terms

F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP.

F2: Represents Restricted Stock Units that have vested as the Common Stock set forth in Table I.

IQVIA HOLDINGS INC.

Report date May 11, 2022 · Filed May 13, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	13,533	Reported balance After 2022-05-11 transaction · row 1 1 source row Row 1 · 2022-05-11 · Grant · Acquired 995 · Balance 13,533 F1: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Filing footnotes · ownership attribution and instrument terms

F1: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

IMS Health Holdings, Inc.

Report date October 03, 2016 · Filed October 03, 2016

Section 16 reporting ended · disclosed 2016-10-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2016-10-03 transaction · row 1 1 source row Row 1 · 2016-10-03 · Disposition to issuer · Disposed 142,840 · Balance 0 F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. F2: Disposed of pursuant to merger agreement in exchange for 54,849 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2020-07-20	Direct	Reported balance After 2016-10-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2016-10-03 · Disposition to issuer · Disposed 20,000 · Balance 0 F3: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.80 · Expires 2020-07-20	Direct	Reported balance After 2016-10-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-10-03 · Disposition to issuer · Disposed 10,000 · Balance 0 F4: This option was assumed by Quintiles in the merger and replaced with an option to purchase 3,840 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.20 · Expires 2020-07-20	Direct	Reported balance After 2016-10-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2016-10-03 · Disposition to issuer · Disposed 20,000 · Balance 0 F5: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.

Filing footnotes · ownership attribution and instrument terms

F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.

F2: Disposed of pursuant to merger agreement in exchange for 54,849 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.

F3: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.

F4: This option was assumed by Quintiles in the merger and replaced with an option to purchase 3,840 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.

F5: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.

TENET HEALTHCARE CORP

Report date September 30, 2022 · Filed October 04, 2022

Section 16 reporting ended · disclosed 2022-10-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	440,235	Reported balance After 2022-09-30 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2022-09-30 · Exercise / conversion · Acquired 32,702 · Balance 440,235 F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	Direct	427,366	Reported balance After 2022-09-30 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2022-09-30 · Tax withholding · Disposed 12,869 · Balance 427,366 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
Common StockSEC Table I · non-derivative	Direct	451,018	Reported balance After 2022-09-30 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2022-09-30 · Exercise / conversion · Acquired 23,652 · Balance 451,018 F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	Direct	441,710	Reported balance After 2022-09-30 transaction · row 4 Account or security details depend on footnotes; rows are not merged. 1 source row Row 4 · 2022-09-30 · Tax withholding · Disposed 9,308 · Balance 441,710 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
Common StockSEC Table I · non-derivative	Direct	446,593	Reported balance After 2022-09-30 transaction · row 5 Account or security details depend on footnotes; rows are not merged. 1 source row Row 5 · 2022-09-30 · Exercise / conversion · Acquired 4,883 · Balance 446,593 F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	Direct	444,671	Reported balance After 2022-09-30 transaction · row 6 Account or security details depend on footnotes; rows are not merged. 1 source row Row 6 · 2022-09-30 · Tax withholding · Disposed 1,922 · Balance 444,671 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
2020 February Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	32,702	Reported balance After 2022-09-30 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-09-30 · Exercise / conversion · Disposed 32,702 · Balance 32,702 F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments.
2021 February Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	23,652	Reported balance After 2022-09-30 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-09-30 · Exercise / conversion · Disposed 23,652 · Balance 23,652 F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments.
2022 February Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	43,950	Reported balance After 2022-09-30 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-09-30 · Exercise / conversion · Disposed 4,883 · Balance 43,950 F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments.
Common StockSEC Table I · non-derivative	IndirectBy spouse	15,000	Reported balance Holding disclosure · report date 2022-09-30 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 15,000

Filing footnotes · ownership attribution and instrument terms

F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments.

F2: Restricted stock units convert into common stock on a one-for-one basis.

F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments.

F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 30, 2021 Filed Oct 4, 2021 21:20 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	12,868	$66.44	$854,949.92	Disclosure SEC source: 0001209191-21-059068 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776,027 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
September 30, 2021 Filed Oct 4, 2021 21:20 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	32,701	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-059068 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The sixth vesting date occurred on September 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 163,507 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2021 February Restricted Stock Units · Derivative	23,652	$0.00	$0.00	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · derivative · entry 10 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,912 Underlying: Common Stock · 23,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 141,912 restricted stock units are shown in Table II. F5 · derivative.exercise_date: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 141,912 restricted stock units are shown in Table II. F5 · derivative.expiration_date: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 141,912 restricted stock units are shown in Table II. F6 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2020 February Restricted Stock Units · Derivative	32,701	$0.00	$0.00	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · derivative · entry 9 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,208 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fifth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 196,208 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fifth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 196,208 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fifth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 196,208 restricted stock units are shown in Table II. F6 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · derivative · entry 8 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The ninth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The ninth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The ninth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. F6 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	9,308	$66.99	$623,542.92	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · nonDerivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,194 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	23,652	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · nonDerivative · entry 5 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 765,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 141,912 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	12,868	$66.99	$862,027.32	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741,850 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	32,701	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fifth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 196,208 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	24,755	$66.99	$1,658,337.45	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 722,017 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:44 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-045004 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The ninth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
April 15, 2021 Filed Apr 19, 2021 21:02 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	934	$0.00	$0.00	Disclosure SEC source: 0001478242-21-000035 · wf-form4_161886613659160.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,828 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2021 February Restricted Stock Units · Derivative	23,651	$0.00	$0.00	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · derivative · entry 10 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,564 Underlying: Common Stock · 23,651 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The first vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 23,651 shares of common stock, as shown in Table I. The remaining 165,564 restricted stock units are shown in Table II. F5 · derivative.exercise_date: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The first vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 23,651 shares of common stock, as shown in Table I. The remaining 165,564 restricted stock units are shown in Table II. F5 · derivative.expiration_date: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The first vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 23,651 shares of common stock, as shown in Table I. The remaining 165,564 restricted stock units are shown in Table II. F6 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2020 February Restricted Stock Units · Derivative	32,701	$0.00	$0.00	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · derivative · entry 9 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,909 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fourth vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 228,909 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fourth vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 228,909 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fourth vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 228,909 restricted stock units are shown in Table II. F6 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · derivative · entry 8 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,908 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The eighth vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 62,908 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The eighth vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 62,908 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The eighth vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 62,908 restricted stock units are shown in Table II. F6 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	9,307	$52.00	$483,964.00	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · nonDerivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,864 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	23,651	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · nonDerivative · entry 5 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 693,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The first vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 23,651 shares of common stock, as shown in Table I. The remaining 165,564 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	12,868	$52.00	$669,136.00	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 669,520 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	32,701	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 682,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fourth vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 228,909 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	24,755	$52.00	$1,287,260.00	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,687 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:35 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-024622 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 674,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The eighth vesting date occurred on March 31, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 62,908 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
February 24, 2021 Filed Feb 27, 2021 00:50 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Grant2021 February Restricted Stock Units · Derivative	189,215	$0.00	$0.00	Disclosure SEC source: 0001209191-21-015031 · doc4.xml · derivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,215 Underlying: Common Stock · 189,215 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest and settle in eight equal quarterly installments on the following dates: March 31, 2021; June 30, 2021; September 30, 2021; December 31, 2021; March 31, 2022; June 30, 2022; September 30, 2022; and December 31, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest and settle in eight equal quarterly installments on the following dates: March 31, 2021; June 30, 2021; September 30, 2021; December 31, 2021; March 31, 2022; June 30, 2022; September 30, 2022; and December 31, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest and settle in eight equal quarterly installments on the following dates: March 31, 2021; June 30, 2021; September 30, 2021; December 31, 2021; March 31, 2022; June 30, 2022; September 30, 2022; and December 31, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
December 31, 2020 Filed Jan 6, 2021 00:14 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2020 February Restricted Stock Units · Derivative	32,701	$0.00	$0.00	Disclosure SEC source: 0001209191-21-001614 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,610 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The third vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 261,610 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The third vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 261,610 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The third vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 261,610 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
December 31, 2020 Filed Jan 6, 2021 00:14 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-21-001614 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,816 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The seventh vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 125,816 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The seventh vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 125,816 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The seventh vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 125,816 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
December 31, 2020 Filed Jan 6, 2021 00:14 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	12,868	$39.93	$513,819.24	Disclosure SEC source: 0001209191-21-001614 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611,534 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
December 31, 2020 Filed Jan 6, 2021 00:14 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	32,701	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-001614 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The third vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 261,610 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
December 31, 2020 Filed Jan 6, 2021 00:14 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	21,175	$39.93	$845,517.75	Disclosure SEC source: 0001209191-21-001614 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,701 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
December 31, 2020 Filed Jan 6, 2021 00:14 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-001614 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The seventh vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 125,816 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
December 10, 2020 Filed Dec 14, 2020 23:12 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2017 September Performance Stock Options (Right to Buy) · Derivative	408,526	$16.43 Strike: $16.43	$6,712,082.18	Disclosure SEC source: 0001209191-20-063304 · doc4.xml · derivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 408,526 shares Expires 2022-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This stock option was exercised and the resulting shares were sold in open market broker transactions pursuant to a 10b5-1 trading plan previously adopted by the reporting person. Read SEC document
December 10, 2020 Filed Dec 14, 2020 23:12 UTC	TENET HEALTHCARE CORP THC · Entity 2563	SaleCommon Stock	408,526	$40.00	$16,341,040.00	Disclosure SEC source: 0001209191-20-063304 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549,968 F1 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions pursuant to a 10b5-1 trading plan previously adopted by the reporting person. Read SEC document
December 10, 2020 Filed Dec 14, 2020 23:12 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	408,526	$16.43	$6,712,082.18	Disclosure SEC source: 0001209191-20-063304 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions pursuant to a 10b5-1 trading plan previously adopted by the reporting person. Read SEC document
November 24, 2020 Filed Nov 25, 2020 22:03 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	9,590	$172.96	$1,658,686.40	Disclosure SEC source: 0001478242-20-000080 · wf-form4_160634180732809.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,894 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $172.62 to $173.25 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
November 16, 2020 Filed Nov 18, 2020 22:03 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	40,792	$174.35	$7,112,085.20	Disclosure SEC source: 0001478242-20-000079 · wf-form4_160573697729958.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,484 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $174.01 to $174.79 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
September 30, 2020 Filed Oct 2, 2020 21:22 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2020 February Restricted Stock Units · Derivative	32,701	$0.00	$0.00	Disclosure SEC source: 0001209191-20-053264 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,311 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The second vesting date occurred on September 30, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 294,311 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The second vesting date occurred on September 30, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 294,311 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The second vesting date occurred on September 30, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 294,311 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
September 30, 2020 Filed Oct 2, 2020 21:22 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-20-053264 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,724 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The sixth vesting date occurred on September 30, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 188,724 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The sixth vesting date occurred on September 30, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 188,724 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The sixth vesting date occurred on September 30, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 188,724 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
September 30, 2020 Filed Oct 2, 2020 21:22 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	12,868	$24.51	$315,394.68	Disclosure SEC source: 0001209191-20-053264 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549,968 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
September 30, 2020 Filed Oct 2, 2020 21:22 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	32,701	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-053264 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The second vesting date occurred on September 30, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 294,311 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
September 30, 2020 Filed Oct 2, 2020 21:22 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	24,755	$24.51	$606,745.05	Disclosure SEC source: 0001209191-20-053264 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,135 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
September 30, 2020 Filed Oct 2, 2020 21:22 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-053264 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The sixth vesting date occurred on September 30, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 188,724 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:20 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2020 February Restricted Stock Units · Derivative	32,701	$0.00	$0.00	Disclosure SEC source: 0001209191-20-040287 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,012 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The first vesting date occurred on June 30, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 327,012 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The first vesting date occurred on June 30, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 327,012 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The first vesting date occurred on June 30, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 327,012 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:20 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-20-040287 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,632 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The fifth vesting date occurred on June 30, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 251,632 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The fifth vesting date occurred on June 30, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 251,632 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The fifth vesting date occurred on June 30, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 251,632 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:20 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	12,868	$18.11	$233,039.48	Disclosure SEC source: 0001209191-20-040287 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,982 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:20 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	32,701	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-040287 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The first vesting date occurred on June 30, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 327,012 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:20 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	24,755	$18.11	$448,313.05	Disclosure SEC source: 0001209191-20-040287 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,149 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:20 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-040287 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The fifth vesting date occurred on June 30, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 251,632 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
May 06, 2020 Filed May 8, 2020 21:08 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	1,492	$0.00	$0.00	Disclosure SEC source: 0001478242-20-000034 · edgar.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,277 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document
March 31, 2020 Filed Apr 2, 2020 22:46 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-20-022807 · doc4.xml · derivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,540 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The fourth vesting date occurred on March 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 314,540 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The fourth vesting date occurred on March 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 314,540 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The fourth vesting date occurred on March 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 314,540 restricted stock units are shown in Table II. F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
March 31, 2020 Filed Apr 2, 2020 22:46 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	24,755	$14.40	$356,472.00	Disclosure SEC source: 0001209191-20-022807 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433,996 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
March 31, 2020 Filed Apr 2, 2020 22:46 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-022807 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The fourth vesting date occurred on March 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 314,540 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
March 13, 2020 Filed Mar 13, 2020 19:36 UTC	TENET HEALTHCARE CORP THC · Entity 2563	PurchaseCommon Stock	11,500	$17.18	$197,570.00	Disclosure SEC source: 0001209191-20-018823 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,843 F1 · shares: The shares were purchased in open market broker transactions. F2 · price: The price is the weighted average purchase price of the aggregate number of shares that were purchased by the reporting person. These shares were purchased in multiple transactions at prices ranging from $17.02 to $17.27. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.